Allergists attending the conference this week AAAAI can visit booth # 517 for more information about Phadia and use the results of allergen testing component. Allergists To order the component packages allergens may require for shipping supplies, or ask questions about the program by calling Customer Service at 1.800.346.4346 PirloAllergy or tolerance in children sensitized to peanuts: prevalence and differentiation with the Component-Resolved Diagnostics , published in the January issue of the Journal of Allergy and Clinical Immunology said Phadia Component Resolved Diagnostics as a potentially useful tool to differentiate a patient with peanut sensitization in a patient at risk of a serious allergic reaction. The study found ‘response with Ara h 2 specific IgE may be a useful tool to predict clinical reactivity to peanut in sensitized subjects.’ The study also highlighted the importance of allergy specialists in the management of patients with peanut sensitization. In the study, the results of tests on components allergens were 97 % correlated with true peanut allergy. The study also indicated that the allergenic components may be helpful in the diagnosis of peanut allergy true. Phadia offers nearly 40 different allergens component packages to specialists at the meeting of the AAAAI. These packages include food components of wheat, eggs, soy, nuts, stone fruit, and celery. Allergen components of the test results are available and are widely used in Europe. United States, these test results are only available to allergy specialists for the whole laboratory of immunology reference Phadia developed by the results of laboratory tests. Using the results of allergen testing component, allergists are able to identify the knowledge that a patient with protein components specific allergens.
‘Both studies show that parents matter,’ said McMorris. ‘Despite the fact that colleagues and friends become important influences as adolescents, parents still have a big impact.’
Today, at the 2010 annual meeting of the American Academy of Allergy, Asthma & Immunology Phadia, a world leader in in vitro diagnosis of allergy, has announced plans to provide access to specialists allergenic components of peanuts. These plans support Phadia the aim of developing cooperation with allergy and immunology specialists to advance the understanding of the clinical utility of the test results of allergen component. In addition, Phadia is actively working with FDA clearance of test allergens based component.